Bacillus Calmette-Guerin (BCG) Vaccine and Morbidity From Malaria

PHASE3CompletedINTERVENTIONAL

Enrollment

1,200

Participants

Timeline

Start Date

January 31, 2003

Study Completion Date

December 31, 2003

Conditions

Malaria

Interventions

BIOLOGICAL

BCG

Trial Locations (1)

Bandim Health Project, Bissau

All Listed Sponsors

collaborator

Bandim Health Project

OTHER

collaborator

Hospital Nacional Simao Mendes, Bissau

UNKNOWN

collaborator

Statens Serum Institut

OTHER

lead

London School of Hygiene and Tropical Medicine

OTHER

NCT00131794 - Bacillus Calmette-Guerin (BCG) Vaccine and Morbidity From Malaria | Biotech Hunter | Biotech Hunter